‘Tiny first responders’ use powers for good against skin cancer
Researchers investigating a group of microscopic cells have discovered they can put the brakes on…
Don’t let new habits increase your cancer risk
The COVID-19 pandemic has brought about many changes in the ways we live and work…
Improving pain relief for patients with advanced cancers
A trans-national clinical trial, involving Peter Mac patients, has found stereotactic ablative body radiation therapy…
Bile duct cancer: existing leukaemia treatment could hold promise – mouse study
Salvatore Papa, University of Leeds and Concetta Bubici, Brunel University London Bile duct cancer is a rare but aggressive form…
ASCO 2021 Lung Cancer Roundtable
The Oncology Journal Club Podcast Episode 37 In today’s special ASCO 2021 episode Craig Underhill talks to Gilberto Lopes and…
Study confirms safety and effectiveness of COVID-19 vaccination in people with cancer
Since the early days of the COVID-19 pandemic, there were questions about how people in active cancer treatment would fare…
Bereavement during COVID-19 by Liz Lobb
The COVID-19 pandemic has disrupted every aspect of life, including how we die and how we grieve. The effects of…
Recent Videos
-
Conquering cancer: Global strategy for the elimination of cervical cancer
-
-
-
-
-
Injected Vitamin C Boosts Power of Cancer Immunotherapy in Mice
-
Amplifying others’ voices: meet childhood cancer researcher Claire Wakefield
-
-
ASCO GU 2019 VIDEO: Genitourinary Cancers Symposium Presscast
-
Nobel Prize awarded “for discovery of cancer therapy by inhibition of negative immune regulation”
Cholesterol metabolite induces production of cancer-promoting vesicles
- ASCO 2021: OlympiA trial shows benefits of targeted drug against early-stage breast cancer with BRCA mutation
- ASCO 2021: PARP inhibitor significantly improved disease-free survival in patients with high-risk early-stage HER2-negative breast cancer with BRCA 1/2 mutations
- Treatment reduces breast cancer recurrence by 42% in patients with early-stage breast cancer with an inherited BRCA1 or BRCA2 gene abnormality
